FAC Regimen - CISMeF

Preferred Label : FAC Regimen;

NCIt synonyms : Fluorouracil-Doxorubicin-IV Cyclophosphamide; Fluorouracil/Doxorubicin/Intravenous Cyclophosphamide; Fluorouracil/Doxorubicin/IV Cyclophosphamide; 5-Fluorouracil/Adriamycin/IV Cyclophosphamide; FAC;

NCIt definition : A chemotherapy regimen consisting of fluorouracil, doxorubicin and intravenous cyclophosphamide, used as a treatment for recurrent and metastatic breast cancer.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL525061;

Codes from synonyms : 5993;

Details

Origin ID

C138099;

UMLS CUI

C4521258;

Automatic exact mappings (from CISMeF team)
- Fancc gene [OMIM gene]
- fac- [IUPAC Term]
CISMeF manual mappings
- FAC (fluorouracil + doxorubicin + cyclophosphamide) [ICD-11 Extension code]
Est indiqué pour
- breast cancer [MeSH concept]
False automatic mappings
- FA complementation group C [ORDO Gene]
- Fanconi anemia, Complementation group C [OMIM Phenotype]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
UMLS correspondences (same concept)
- FAC (fluorouracil + doxorubicin + cyclophosphamide) [ICD-11 Extension code]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Doxorubicin [NCIt concept]
- Fluorouracil [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Invasive Breast Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients